Exelon
Exelon capsules contain the active ingredient rivastigmine, which is a type of medicine called an acetylcholinesterase inhibitor. It works by slowing the breakdown of a compound in the brain called acetylcholine.
Acetylcholine is a natural compound known as a neurotransmitter. [More information]
| RRP | : | € 102,20 |
| Our Price | : | € 91,75 |
| You Save | : | € 10,45 (10%) |
| Delivery Time | : | Direct |
| Available | : | Prescription required |
Switch currency
£ GBP
| Product | RRP | Price | Order |
| Exelon 1.5 mg 28 Caps. | € 112,20 | € 91,75 | Add to shopping cart |
| Exelon 1.5 mg 56 Caps. | € 204,25 | € 182,75 | Add to shopping cart |
| Exelon 3 mg 28 Caps. | € 102,20 | € 91,75 | Add to shopping cart |
| Exelon 3 mg 56 Caps. | € 204,25 | € 182,75 | Add to shopping cart |
| Exelon 4.5 mg 28 Caps. | € 102,20 | € 91,75 | Add to shopping cart |
| Exelon 4.5 mg 56 Caps. | € 204,25 | € 182,75 | Add to shopping cart |
| Exelon 4.6 mg 30 Patches | € 199,95 | € 180,75 | Add to shopping cart |
| Exelon 6 mg 28 Caps. | € 102,20 | € 91,75 | Add to shopping cart |
| Exelon 6 mg 56 Caps. | € 204,25 | € 182,75 | Add to shopping cart |
| Exelon 9.5 mg 30 Patches | € 199,95 | € 180,75 | Add to shopping cart |
Patient Leaflet(s)
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
This patient information leaflet (PIL) is provided for informational purposes only. For further manufacturer information please refer to the PIL in the packaging.
product information
Exelon capsules contain the active ingredient rivastigmine, which is a type of medicine called an acetylcholinesterase inhibitor. It works by slowing the breakdown of a compound in the brain called acetylcholine.
Acetylcholine is a natural compound known as a neurotransmitter. Neurotransmitters are stored in nerve cells in the brain and nervous system, and are involved in transmitting messages between the nerve cells. They are necessary for the normal functioning of the brain and nervous system. Acetylcholine in the brain is continually being released by nerve cells, and then broken down by another natural chemical called acetylcholinesterase.
One of the features of both Alzheimer's disease and Parkinson's disease appears to be a lower than normal level of acetylcholine in the brain. This is due in part to degeneration of brain cells, in particular those that normally release acetylcholine.
Rivastigmine increases the level of acetylcholine in the brain. It does this by preventing the action of acetylcholinesterase, the compound that normally breaks it down. This slows the breakdown of acetylcholine that is released from remaining undamaged nerve cells in the brain.
The result of this is increased activity of acetylcholine in the brain. This improves the cognitive processes of thinking, learning and memory, and improves the symptoms of dementia and daily functioning in Alzheimer's disease.
Rivastigmine is used to treat mild to moderately severe dementia in people with Alzheimer's disease or Parkinson's disease. However, it only slows the worsening of the dementia, rather than being a cure. If the medicine has not slowed the worsening of symptoms after three months of treatment at the maintenance dose, it should be stopped. For people who continue treatment, the benefit of the medicine should be reassessed on a regular basis, and treatment should be stopped when it is considered that the medicine is no longer providing a beneficial effect.
Exelon capsules and oral soution are taken by mouth twice a day.
